作者
Melissa Matz, Michel P Coleman, Helena Carreira, Diego Salmerón, Maria Dolores Chirlaque, Claudia Allemani, S Bouzbid, M Hamdi-Chérif, Z Zaidi, E Bah, R Swaminathan, SH Nortje, MM El Mistiri, S Bayo, B Malle, SS Manraj, R Sewpaul-Sungkur, A Fabowale, OJ Ogunbiyi, D Bradshaw, NIM Somdyala, DC Stefan, M Abdel-Rahman, L Jaidane, M Mokni, I Kumcher, F Moreno, MS González, EA Laura, SB Espinola, GH Calabrano, B Carballo Quintero, R Fita, DA Garcilazo, PL Giacciani, MC Diumenjo, WD Laspada, MA Green, MF Lanza, SG Ibañez, CA Lima, E Lobo de Oliveira, C Daniel, C Scandiuzzi, PCF De Souza, CD Melo, K Del Pino, C Laporte, MP Curado, JC de Oliveira, CLA Veneziano, DB Veneziano, MRDO Latorre, LF Tanaka, G Azevedo e Silva, JC Galaz, JA Moya, DA Herrmann, S Vargas, VM Herrera, CJ Uribe, LE Bravo, NE Arias-Ortiz, DM Jurado, MC Yépez, YH Galán, P Torres, F Martínez-Reyes, ML Pérez-Meza, L Jaramillo, R Quinto, P Cueva, JG Yépez, CR Torres-Cintrón, G Tortolero-Luna, R Alonso, E Barrios, C Nikiforuk, L Shack, AJ Coldman, RR Woods, G Noonan, D Turner, E Kumar, B Zhang, FR McCrate, S Ryan, H Hannah, RAD Dewar, M MacIntyre, A Lalany, M Ruta, L Marrett, DE Nishri, C McClure, KA Vriends, C Bertrand, R Louchini, KI Robb, H Stuart-Panko, S Demers, S Wright, JT George, X Shen, JT Brockhouse, DK O'Brien, KC Ward, L Almon, J Bates, R Rycroft, L Mueller, C Phillips, H Brown, B Cromartie, AG Schwartz, F Vigneau, JA MacKinnon, B Wohler, AR Bayakly, CA Clarke, SL Glaser, D West, MD Green, BY Hernandez, CJ Johnson, D Jozwik, ME Charlton, CF Lynch, B Huang, TC Tucker, D Deapen, L Liu, MC Hsieh, XC Wu, K Stern, ST Gershman, RC Knowlton, J Alverson, GE Copeland, DB Rogers, D Lemons, LL Williamson, M Hood, GM Hosain, JR Rees, KS Pawlish, A Stroup, C Key, C Wiggins, AR Kahn
发表日期
2017/2/1
期刊
Gynecologic oncology
卷号
144
期号
2
页码范围
396-404
出版商
Elsevier
简介
Objective
Ovarian cancer comprises several histological groups with widely differing levels of survival. We aimed to explore international variation in survival for each group to help interpret international differences in survival from all ovarian cancers combined. We also examined differences in stage-specific survival.
Methods
The CONCORD programme is the largest population-based study of global trends in cancer survival, including data from 60 countries for 695,932 women (aged 15–99 years) diagnosed with ovarian cancer during 1995–2009. We defined six histological groups: type I epithelial, type II epithelial, germ cell, sex cord-stromal, other specific non-epithelial and non-specific morphology, and estimated age-standardised 5-year net survival for each country by histological group. We also analysed data from 67 cancer registries for 233,659 women diagnosed from 2001 to 2009, for whom information on …
学术搜索中的文章
M Matz, MP Coleman, H Carreira, D Salmerón… - Gynecologic oncology, 2017